Switzerland· 62764004
Selincro, Filmtabletten
A nalmefene product containing nalmefenum, registered in Switzerland by Lundbeck (Schweiz) AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Nalmefene is registered in 14 of 19 countries.
Countries holding a registration under ATC N07BB05 (nalmefene), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Nalmefene · ATC N07BB05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nalmefene costs, country by country.
Normalised to the WHO defined daily dose (18 mg), the median price runs from $3.31 in France to $6.33 in Switzerland — a ×1.9 gap.
- Switzerland: $6.33 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Nalmefene · price per daily dose (18 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.33
- FR France$3.31
The record
At a glance
Swissmedic (Switzerland)- Active substance
- nalmefenum
- Manufacturer
- Lundbeck (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- N07BB05
- ATC class
- Nalmefene
- Defined daily dose
- 18 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768062764004442 StkCHF 196.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for nalmefene.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nalmefene · interactions on record
5 records
- 4 moderate
- 1 minor
Most severe, free to view
- Methylnaltrexone bromideA06AH01moderate
- NaloxegolA06AH03moderate
- NaldemedineA06AH05moderate
- GlimepirideA10BB12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nalmefene in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSELINCROH. Lundbeck A/S, Valby
- SpainSELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULAH. Lundbeck A/S
- FinlandSelincroH. Lundbeck A/S
- FranceSELINCRO 18 mg, comprimé pelliculéLUNDBECK (DANEMARK)
- IrelandSelincro 18 mg film-coated tabletsH. Lundbeck A/S
- IcelandSelincroH. Lundbeck A/S*
- NetherlandsSelincro 18 mg, filmomhulde tabletH. Lundbeck A/S
- NorwaySelincroH.Lundbeck
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Nalfino
- France · Nalmefene Biogaran
- Iceland · Selincro
- Norway · Selincro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2be2875d-5c50-4fab-86ef-41bb1052dbb9 GET /v1/drugs/2be2875d-5c50-4fab-86ef-41bb1052dbb9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "nalmefenum 18 mg",
"valid_from": "2014-11-01",
"limitations": "[{\"description\":\"Zur Reduktion des Alkoholkonsums bei erwachsenen Patienten mit Alkoholabhängigkeit, deren Alkoholkonsum sich auf einem hohen Risiko-Niveau gemäss WHO Drinking Risk Levels (DRLs) für Alkoholkonsum befindet (Alkoholkonsum >60 g/Tag für Männer und >40 g/Tag für Frauen an einem Heavy Drinking Day), bei denen keine körperlichen Entzugserscheinungen vorliegen, und für die keine sofortige Entgiftung erforderlich ist.<br>\\nDie Diagnose der Alkoholabhängigkeit, die Verschreibung, Überwachung und Dokumentation der Therapie muss durch einen geeignet qualifizierten Arzt mit Erfahrung in der Therapie von Alkoholabhängigen erfolgen.<br>\\nDie Behandlung darf nur bei Patienten eingeleitet werden, deren Alkoholkonsum sich 2 Wochen nach einer initialen Untersuchung weiterhin auf einem hohen Risiko-Niveau befindet.<br>\\nNur als zusätzliche Behandlung in Verbindung mit kontinuierlicher psychosozialer Unterstützung, die auf Therapieadhärenz und eine Reduktion des Alkoholkonsums zielt.<br>\\nDie Vergütung erfolgt über einen Zeitraum von maximal 12 Monaten. Eine Vergütung >12 Monate ist nur nach Kostengutsprache nach Evaluation des Behandlungserfolgs und des weiteren Behandlungsbedarfs durch den Vertrauensarzt vorgesehen.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2014-11-01\"}]",
"galenic_form": "Filmtabl 18 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2014-11-01",
"self_retention_pct": 10
}See everything about nalmefene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.